CSIMarket
 


Becton Dickinson And Company  (BDX)
Other Ticker:  
 

Becton Dickinson's Leverage Ratio

BDX's quarterly Leverage Ratio and Total Liabilities, Equity growth


Due to repayements of liabilities of -1.35% Becton Dickinson improved Leverage Ratio in forth quarter 2023 to 0.87, below the company's average Leverage Ratio.

Within Medical Equipment & Supplies industry in the forth quarter 2023, 110 other companies have achieved lower Leverage Ratio than Becton Dickinson in the IV Quarter 2023. While Leverage Ratio total ranking has improved so far in the forth quarter 2023 to 1570, from total ranking in the third quarter 2023 at 1687 .

Explain Leverage Ratio?
Who are BDX Customers?
What are BDX´s Total Liabilities?


BDX Leverage Ratio (Sep 30 2023)
IV. Quarter
(Jun 30 2023)
III. Quarter
(Mar 31 2023)
II. Quarter
(Dec 31 2022)
I. Quarter
(Sep 30 2022)
IV. Quarter
Y / Y Equity Change 2.03 % 1.74 % 4.75 % 5.43 % 6.78 %
Y / Y Total Liabilities Change -0.87 % -18.04 % -19.92 % -21.94 % -25.14 %
Leverage Ratio MRQ 0.87 0.88 0.94 0.89 0.89
BDX's Total Ranking # 1570 # 1687 # 1737 # 808 # 1549
Seq. Equity Change -0.54 % 0.97 % 0.85 % 0.75 % -0.83 %
Seq. Total Liabilities Change -1.35 % -6.3 % 6.31 % 0.87 % -18.43 %



Leverage Ratio forth quarter 2023 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 111
Healthcare Sector # 561
Overall Market # 1570


Leverage Ratio Statistics
High Average Low
2.95 1.27 0.33
(March 31, 2015)   (June 30. 2010)




Financial Statements
Becton Dickinson's Equity $ 25,796 Millions Visit BDX's Balance sheet
Becton Dickinson's Total Liabilities $ 22,402 Millions Visit BDX's Balance sheet
Source of BDX's Sales Visit BDX's Sales by Geography


Cumulative Becton Dickinson's Leverage Ratio

BDX's Leverage Ratio for the trailling 12 Months

BDX Leverage Ratio

(Sep 30 2023)
IV. Quarter
(Jun 30 2023)
III. Quarter
(Mar 31 2023)
II. Quarter
(Dec 31 2022)
I. Quarter
(Sep 30 2022)
IV. Quarter
Y / Y Equity TTM Growth 2.03 % 1.74 % 4.75 % 5.43 % 6.78 %
Y / Y Total Liabilities TTM Growth -0.87 % -18.04 % -19.92 % -21.94 % -25.14 %
Leverage Ratio TTM 0.9 0.9 0.95 1.03 1.1
Total Ranking TTM # 1019 # 1836 # 1968 # 2047 # 2419
Seq. Equity TTM Growth -0.54 % 0.97 % 0.85 % 0.75 % -0.83 %
Seq. Total Liabilities TTM Growth -1.35 % -6.3 % 6.31 % 0.87 % -18.43 %


On the trailing twelve months basis Due to repayements of liabilities of -1.35% Becton Dickinson has not changed Leverage Ratio in the 12 months ending in IV Quarter 2023 to 0.9, below the company's average Leverage Ratio.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Medical Equipment & Supplies industry BDX recorded the lowest Leverage Ratio. While Leverage Ratio total ranking has improved so far to 3, from total ranking in previous 12 month period at 8.

Explain Leverage Ratio?
Who are BDX Customers?
What are BDX´s Total Liabilities?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 0
Healthcare Sector # 1
Within the Market # 1570


trailing twelve months Leverage Ratio Statistics
High Average Low
2.52 1.26 0.6
(June 30. 2015)   (March 31, 2009)




Companies with similar Leverage Ratio in the quarter ending Sep 30 2023, within Medical Equipment & Supplies Industry Leverage RatioSep 30 2023 MRQ Total LiabilitiesSep 30 2023 MRQ Equity
Helius Medical Technologies inc   1.93 $ 5.833  Millions$ 3.021  Millions
Strata Skin Sciences Inc   1.91 $ 31.000  Millions$ 16.193  Millions
Tenon Medical Inc   1.91 $ 4.801  Millions$ 2.517  Millions
Iridex Corp  1.90 $ 22.885  Millions$ 12.064  Millions
Dexcom Inc   1.86 $ 4,214.900  Millions$ 2,267.900  Millions
Tela Bio Inc   1.86 $ 56.765  Millions$ 30.552  Millions
Artivion Inc   1.85 $ 502.812  Millions$ 271.975  Millions
Conmed Corporation  1.84 $ 1,462.557  Millions$ 796.205  Millions
Vaso Corporation  1.76 $ 45.011  Millions$ 25.609  Millions
Soleno Therapeutics Inc  1.74 $ 40.328  Millions$ 23.220  Millions
Novocure Limited  1.71 $ 675.156  Millions$ 393.704  Millions
Acutus Medical Inc   1.67 $ 53.022  Millions$ 31.706  Millions
Patterson Companies Inc   1.67 $ 1,761.001  Millions$ 1,055.089  Millions
Escalon Medical Corp   1.58 $ 3.015  Millions$ 1.914  Millions
Cytosorbents Corporation  1.57 $ 29.063  Millions$ 18.512  Millions
Reshape Lifesciences Inc   1.54 $ 4.744  Millions$ 3.083  Millions
Zynex inc   1.53 $ 89.565  Millions$ 58.582  Millions
Msa Safety Incorporated  1.53 $ 1,325.609  Millions$ 868.726  Millions
Shockwave Medical Inc   1.45 $ 872.714  Millions$ 601.245  Millions
Neuronetics inc   1.36 $ 51.701  Millions$ 37.941  Millions
Masimo Corp  1.35 $ 1,720.300  Millions$ 1,275.600  Millions
Sonendo Inc   1.30 $ 49.213  Millions$ 37.780  Millions
Adm Tronics Unlimited Inc   1.27 $ 1.535  Millions$ 1.207  Millions
Integra Lifesciences Holdings Corp  1.21 $ 1,917.680  Millions$ 1,579.221  Millions
Cadre Holdings Inc   1.21 $ 230.508  Millions$ 189.997  Millions
Nuo Therapeutics Inc   1.20 $ 0.873  Millions$ 0.727  Millions
Henry Schein Inc  1.18 $ 5,051.000  Millions$ 4,280.000  Millions
Dentsply Sirona Inc   1.13 $ 3,826.000  Millions$ 3,371.000  Millions
Haemonetics Corporation  1.13 $ 1,012.877  Millions$ 893.660  Millions
Movano Inc   1.13 $ 5.602  Millions$ 4.944  Millions

Date modified: 2024-02-02T18:45:37+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com